Page last updated: 2024-08-17

carbostyril and Carcinoma, Anaplastic

carbostyril has been researched along with Carcinoma, Anaplastic in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (18.18)18.2507
2000's3 (27.27)29.6817
2010's5 (45.45)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Choi, HY; Gualberto, A; Jeong, BC; Kwon, GY; Lee, HW; Park, SH; Sa, JK; Scholz, C; Sung, HH1
Bjarnason, GA; Edeline, J; Escudier, B; Faivre, S; Fartoux, L; Germann, N; Hirte, H; Jones, R; Mackay, H; Oza, A; Plummer, R; Pouget, JC; Thistlethwaite, F; Van Cutsem, E; Vergote, I1
Chen, SS; Lin, ML; Ng, SH1
Chaurasia, M; Chowdhury, T; Das, S; Dey, KK; Mandal, M; Pal, I; Parida, S; Rajesh, Y; Sharma, K1
Akhmedjanova, V; Aubert, C; Ciccolini, J; Ea, S; Giacometti, S1
Agarwal, N; Sonpavde, G; Sternberg, CN1
Baek, IH; Baik, GH; Choi, MH; Jang, HJ; Kae, SH; Kim, HY; Kim, JH; Kim, KH; Kim, KO; Kim, SJ; Park, CH; Shin, WG1
Chao, JI; Hsu, TS; Kuo, PC1
Chao, JI; Chen, C; Chiu, SJ; Hsu, TS; Lee, PT; Liu, HF; Tsai, CC1
Beumer, H; Hoepelman, AI; Rozenberg-Arska, M; Verhoef, J; Visser, MR1
Arakawa, H; Iguchi, T; Kurama, M; Mano, E; Nakagawa, S; Okura, A; Tanaka, N; Yoshinari, T1

Reviews

1 review(s) available for carbostyril and Carcinoma, Anaplastic

ArticleYear
Novel molecular targets for the therapy of castration-resistant prostate cancer.
    European urology, 2012, Volume: 61, Issue:5

    Topics: Abiraterone Acetate; Androstadienes; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Neoplasms; Cancer Vaccines; Carcinoma; Clinical Trials, Phase III as Topic; Clusterin; Dasatinib; Denosumab; Humans; Ipilimumab; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Pyridines; Pyrimidines; Quinolines; Quinolones; Radium; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids; Thiazoles; Tissue Extracts; Treatment Outcome; Vaccines, Synthetic

2012

Trials

3 trial(s) available for carbostyril and Carcinoma, Anaplastic

ArticleYear
A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 10-01, Volume: 26, Issue:19

    Topics: Aged; AMP-Activated Protein Kinase Kinases; Carcinoma; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mutation; Neoplasm Metastasis; Progression-Free Survival; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins p21(ras); Quinolones; Urothelium

2020
A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers.
    Targeted oncology, 2017, Volume: 12, Issue:5

    Topics: Antineoplastic Agents; Carcinoma; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Liver Neoplasms; Male; Ovarian Neoplasms; Quinolones; Stomach Neoplasms

2017
Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
    Gastrointestinal endoscopy, 2012, Volume: 75, Issue:4

    Topics: Adenoma; Aged; Alanine; Anti-Ulcer Agents; Carcinoma; Chi-Square Distribution; Confidence Intervals; Dissection; Drug Therapy, Combination; Female; Gastric Mucosa; Gastroscopy; Humans; Male; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Quinolones; Stomach Neoplasms; Stomach Ulcer

2012

Other Studies

7 other study(ies) available for carbostyril and Carcinoma, Anaplastic

ArticleYear
CHM-1 Suppresses Formation of Cell Surface-associated GRP78-p85α Complexes, Inhibiting PI3K-AKT Signaling and Inducing Apoptosis of Human Nasopharyngeal Carcinoma Cells.
    Anticancer research, 2015, Volume: 35, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Dioxoles; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphatidylinositol 3-Kinase; Protein Multimerization; Proto-Oncogene Proteins c-akt; Quinolones; Signal Transduction

2015
Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:5

    Topics: Apoptosis; Benzimidazoles; Carcinoma; Celecoxib; Colonic Neoplasms; Combined Modality Therapy; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; HCT116 Cells; Humans; Quinolones; Radiation Tolerance; Radiation-Sensitizing Agents; Radiation, Ionizing; Signal Transduction

2016
Cytotoxic effects of haplamine and its major metabolites on human cancer cell lines.
    Planta medica, 2008, Volume: 74, Issue:10

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Digestive System Neoplasms; Fluorouracil; Gemcitabine; Humans; Pyrans; Quinolones; Rutaceae

2008
Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells.
    The Journal of biological chemistry, 2004, May-07, Volume: 279, Issue:19

    Topics: Antineoplastic Agents; Apoptosis; Arsenites; Benzazepines; Blotting, Western; Carcinoma; CDC2 Protein Kinase; Cell Cycle; Cell Division; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Down-Regulation; Fluorescent Antibody Technique, Indirect; G2 Phase; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Indoles; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Male; MAP Kinase Signaling System; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinases; Mitosis; Neoplasm Proteins; Nitric Oxide; Nitroprusside; p38 Mitogen-Activated Protein Kinases; Penicillamine; Purines; Pyridines; Quercetin; Quinolones; Quinones; Reverse Transcriptase Polymerase Chain Reaction; Survivin; Time Factors; Transfection

2004
7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway.
    Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma; CDC2 Protein Kinase; Cell Count; Cell Cycle; Cell Death; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Humans; Lung Neoplasms; Membrane Potentials; Mitochondrial Membranes; Mitogen-Activated Protein Kinases; Phosphorylation; Quinolones; Quinones; Signal Transduction; Tumor Suppressor Protein p53

2008
Changes in adherence of respiratory pathogens to HEp-2 cells induced by subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:4

    Topics: Anti-Infective Agents; Bacteria; Bacterial Adhesion; Carcinoma; Ciprofloxacin; Fluoroquinolones; Humans; Laryngeal Neoplasms; Quinolones; Respiratory Tract Infections; Trimethoprim; Tumor Cells, Cultured

1993
Stereo (C7)-dependent topoisomerase II inhibition and tumor growth suppression by a new quinolone, BO-2367.
    Japanese journal of cancer research : Gann, 1993, Volume: 84, Issue:7

    Topics: Animals; Anti-Infective Agents; Carcinoma; Colonic Neoplasms; DNA Topoisomerases, Type II; DNA, Neoplasm; DNA, Superhelical; Drug Screening Assays, Antitumor; Enzyme Induction; Etoposide; Female; Fluoroquinolones; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred Strains; Quinolones; Stereoisomerism; Topoisomerase II Inhibitors

1993